The Effects of an Infant Formula Containing Hydrolysed Proteins on Growth and Tolerance in Healthy Term Infants
A Randomized, Controlled, Double-blind Parallel Group Trial to Study the Effects of an Infant Formula Containing Partially Hydrolysed Proteins on Growth and Tolerance in Healthy Term Infants
1 other identifier
interventional
345
1 country
3
Brief Summary
In this clinical trial, weight gain (primary objective), and additional anthropometry (secondary objectives), of infants exclusively consuming a hydrolysed protein-based infant formula were evaluated and compared to a standard intact protein-based formula over a period of at least three months, until the age of 17 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2021
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 6, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 24, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 24, 2022
CompletedFirst Submitted
Initial submission to the registry
February 24, 2023
CompletedFirst Posted
Study publicly available on registry
March 7, 2023
CompletedSeptember 22, 2023
September 1, 2023
1.2 years
February 24, 2023
September 21, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
weight gain
weight gain in g/day
until 17 weeks of age
Secondary Outcomes (9)
Weight
until 17 weeks of age
Length
until 17 weeks of age
head circumference
until 17 weeks of age
BMI
until 17 weeks of age
WAZ
until 17 weeks of age
- +4 more secondary outcomes
Other Outcomes (1)
formula intake
until 17 weeks of age
Study Arms (2)
test formula
EXPERIMENTALhydrolysed protein-based infant formula
control formula
ACTIVE COMPARATORstandard intact protein-based formula
Interventions
infant formula based on hydrolysed protein
Eligibility Criteria
You may qualify if:
- Full-term infants (born at gestational age =37 weeks).
- Healthy birthweight (according to WHO Child Growth Standards): between 2500 and 4200 g, retrieved from medical records
- Boys and girls
- Apparently healthy at birth and screening
- Weight-for-age Z-score (WAZ), weight-for-length (WHZ), and length-for-age (LAZ) Z-scores at screening within the normal range according to WHO Child Growth Standards (i.e. -2 = WAZ,WHZ,LAZ = 2)
- Age at enrolment: =28 days of age
- Exclusively formula fed during the entire intervention period
- Parents agreeing to initiate complementary feeding after finalization of the study
- Being available for follow up until the age of approximately 3.5 months
- Written informed consent from parent(s) and/or legal guardian(s) aged =18 years
You may not qualify if:
- Gestational age \<37 weeks
- Birth weight \<2500 g or \>4200 g
- Age at enrolment: \>28 days
- Severe acquired or congenital diseases, mental or physical disorders, including cow's milk protein allergy, lactose intolerance and diagnosed medical conditions that are known to affect growth (i.e. GI disorders)
- Incapability of parents to comply with the study protocol
- Illiterate parents (i.e. not able to read and write in local language)
- Participation in another clinical trial
- Unwillingness to accept the formula supplied by the study as the only formula for their child during study participation
- infants fed a special diet other than standard, non-hydrolysed, cow's or goat's milk based infant formula
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- FrieslandCampinalead
Study Sites (3)
Department of Nutrition and Dietetics, University of Thessaly
Trikala, Thessaly, 42132, Greece
Harokopio University
Athens, Thiseos 70, Kallithea 176 71, Greece
Department of Nutritional Sciences, International Hellenic University
Thessaloniki, 55535, Greece
Related Publications (1)
Kantaras P, Kokkinopoulou A, Hageman JHJ, Hassapidou M, Androutsos O, Kanaki M, Bovee-Oudenhoven I, Karaglani E, Kontochristopoulou AM, Bos R, Manios Y. Growth and gut comfort of healthy term infants exclusively fed with a partially hydrolysed protein-based infant formula: a randomized controlled double-blind trial. Front Pediatr. 2024 May 17;12:1328709. doi: 10.3389/fped.2024.1328709. eCollection 2024.
PMID: 38827219DERIVED
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Yannis Manios, Prof
Harokopio University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 24, 2023
First Posted
March 7, 2023
Study Start
August 6, 2021
Primary Completion
October 24, 2022
Study Completion
October 24, 2022
Last Updated
September 22, 2023
Record last verified: 2023-09